4//SEC Filing
Baxter Nicholas W 4
Accession 0001348362-24-000002
CIK 0001348362other
Filed
Jul 29, 8:00 PM ET
Accepted
Jul 30, 11:25 AM ET
Size
14.8 KB
Accession
0001348362-24-000002
Insider Transaction Report
Form 4
Baxter Nicholas W
Director
Transactions
- Award
Stock Options
2024-07-26+12,000→ 52,000 totalExercise: $3.39From: 2024-07-26Exp: 2029-07-26→ Common Shares (12,000 underlying)
Holdings
- 6,500
Stock Options
Exercise: $3.00From: 2021-06-08Exp: 2026-06-08→ Common Shares (5,000 underlying) - 8,400
Stock Options
Exercise: $3.00From: 2021-09-01Exp: 2026-09-01→ Common Shares (1,900 underlying) - 11,800
Stock Options
Exercise: $3.39From: 2022-03-08Exp: 2027-03-08→ Common Shares (3,400 underlying) - 1,500
Stock Options
Exercise: $3.00From: 2021-04-26Exp: 2026-04-26→ Common Shares (1,500 underlying) - 11,000
common shares
- 30,000
Stock Options
Exercise: $1.96From: 2022-10-12Exp: 2027-10-12→ Common Shares (18,200 underlying) - 35,000
Stock Options
Exercise: $0.87From: 2023-07-25Exp: 2028-07-25→ Common Shares (5,000 underlying) - 40,000
Stock Options
Exercise: $2.36From: 2024-04-26Exp: 2029-04-26→ Common Shares (5,000 underlying)
Footnotes (3)
- [F1]Repriced from $5.31 pursuant to shareholder approval received May 9, 2023
- [F2]Repriced from $7.08 pursuant to shareholder approval received May 9, 2023
- [F3]Repriced from $6.23 pursuant to shareholder approval received May 9, 2023
Documents
Issuer
Lexaria Bioscience Corp.
CIK 0001348362
Entity typeother
Related Parties
1- filerCIK 0001312326
Filing Metadata
- Form type
- 4
- Filed
- Jul 29, 8:00 PM ET
- Accepted
- Jul 30, 11:25 AM ET
- Size
- 14.8 KB